4.5 Review

Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1863, Issue 9, Pages 2333-2344

Publisher

ELSEVIER
DOI: 10.1016/j.bbamcr.2016.06.009

Keywords

Genome editing; CRISPR; Cas9; Mutation; Indel; sgRNA; Double stranded breaks

Funding

  1. Times of India -Loyola College grant [7LCTOI14ERI001]
  2. Deanship of Scientific Research at King Saud University, Riyadh, Kingdom of Saudi Arabia [0020]
  3. Cancer Research Trainee Program of the Beatrice Hunter Cancer Institute, Nova Scotia
  4. Canadian Imperial Bank of Commerce
  5. New Brunswick Health Research Foundation

Ask authors/readers for more resources

The clustered, regularly interspaced, short palindromic repeat (CRISPR) and CRISPR associated protein 9 (Cas9) system discovered as an adaptive immunity mechanism in prokaryotes has emerged as the most popular tool for the precise alterations of the genomes of diverse species. CRISPR/Cas9 system has taken the world of genome editing by storm in recent years. Its popularity as a tool for altering genomes is due to the ability of Cas9 protein to cause double-stranded breaks in DNA after binding with short guide RNA molecules, which can be produced with dramatically less effort and expense than required for production of transcription-activator like effector nucleases (TALEN) and zinc-finger nucleases (ZFN). This system has been exploited in many species from prokaryotes to higher animals including human cells as evidenced by the literature showing increasing sophistication and ease of CRISPR/Cas9 as well as increasing species variety where it is applicable. This technology is poised to solve several complex molecular biology problems faced in life science research including cancer research. In this review, we highlight the recent advancements in CRISPR/Cas9 system in editing genomes of prokaryotes, fungi, plants and animals and provide details on software tools available for convenient design of CRISPR/Cas9 targeting plasmids. We also discuss the future prospects of this advanced molecular technology. Crown Copyright (C) 2016 Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available